Investors Overview
Quotes are not sourced from all markets and may be delayed. Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.
Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care.
Investor Relations
Precipio, Inc.
4 Science Park, 3rd Floor
New Haven, CT 06511
1.203.787.7888
[email protected]
Corporate Counsel
Goodwin Procter LLP
Stephen Davis
The New York Times Building
620 Eighth Avenue
New York, NY 10018
1.212.813.8804
[email protected]
Auditors
Marcum LLP
Jeffrey Solomon
CityPlace II
185 Asylum Street, 17th Floor
Hartford, CT 06103
1.860.760.0600
http://www.marcumllp.com
[email protected]
Transfer Agent
EQ Shareholder Services,
1110 Centre Pointe Curve, #101
St. Paul, MN 55120
1.800.468.9716
[email protected]

Looking For More Information?

Investor Relations
Visit our investor portal.

Corporate Deck
Who is Precipio?

Clinical Services
Services and products.